Quotient   Report issue

For profit Phase 1 Phase 2
Founded: Notthingham United Kingdom (1990)
Status: Acquired by Pharmaron (2016)

Organization Overview

First Clinical Trial
2010
NCT01253122
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2021

Timeline

NOW
  • Now

Mergers & Acquisitions

Historical Acquisition Tree

Alternative names

QS Pharma | Quotient Bioresearch | Quotient Bioresearch Clinical Services | Quotient Bioresearch Ltd | Quotient Clinical | Quotient Clinical Limited | Quotient Clinical Ltd | Quotient Clinical LTD | Quotient Clinical Ltd, Mere Way, Ruddington Fields, Nottingham, United Kingdom. NG11 6JS | Quotient Clinical Ltd, United Kingdom | Quotient Clinical Mere Way Ruddington Fields Ruddington Nottingham NG11 6JS, UK | Quotient Clinical, Mere Way, Ruddington Fields, Ruddington, Nottinham NG11 6JS, UK | Quotient Clinical, Mere Way, Ruddlington Fields, Nottingham | Quotient Clinical Research | Quotient Clinical Unit | Quotient Sciences | Quotient Sciences Limited (indemnified by | Quotient Sciences Limited (indemnified by Medical Protection Society) | Quotient Sciences Mere Way Ruddington Fields Ruddington Nottingham NG11 6JS, UK | Quotient Sciences - Miami, Inc. | Quotient Sciences Miami Inc. | Quotient Sciences - Nottingham, UK | Quotient Sciences Nottingham, UK, NG116JS | Quotient Sciences Principal Investigator | Senior Medical Director, Quotient Sciences